Related references
Note: Only part of the references are listed.Artemisinin resistance: Cause for worry?
Anurag Khera et al.
JOURNAL OF MARINE MEDICAL SOCIETY (2019)
Efficacy of artesunate-amodiaquine, dihydroartemisinin-piperaquine and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
Francesco Grandesso et al.
MALARIA JOURNAL (2018)
Uneven malaria transmission in geographically distinct districts of Bobo- Dioulasso, Burkina Faso
Dieudonne Diloma Soma et al.
PARASITES & VECTORS (2018)
Seasonal malaria chemoprevention in the Sahel
Alexandra York
LANCET INFECTIOUS DISEASES (2017)
Efficacy of Artesunate/Amodiaquine in the Treatment of Uncomplicated Malaria among Children in Ghana
Benjamin K. Abuaku et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2017)
Bioavailability of Lumefantrine Is Significantly Enhanced with a Novel Formulation Approach, an Outcome from a Randomized, Open-Label Pharmacokinetic Study in Healthy Volunteers
Jay Prakash Jain et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Artesunate/Amodiaquine Versus Artemether/Lumefantrine for the Treatment of Uncomplicated Malaria in Uganda: A Randomized Trial
Adoke Yeka et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
In vivo efficacy of artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria: an open-randomized, non-inferiority clinical trial in South Kivu, Democratic Republic of Congo
Marit de Wit et al.
MALARIA JOURNAL (2016)
Antimalarial drug resistance in Africa: key lessons for the future
Shannon Takala-Harrison et al.
MALARIA: ADVANCES IN PATHOPHYSIOLOGY, BIOLOGY, AND DRUG DEVELOPMENT (2015)
In Vivo Selection of Plasmodium falciparum Pfcrt and Pfmdr1 Variants by Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine in Burkina Faso
Vito Baraka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Selection of Drug Resistance-Mediating Plasmodium falciparum Genetic Polymorphisms by Seasonal Malaria Chemoprevention in Burkina Faso
Anyirekun Fabrice Some et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Ex vivo anti-malarial drugs sensitivity profile of Plasmodium falciparum field isolates from Burkina Faso five years after the national policy change
Halidou Tinto et al.
MALARIA JOURNAL (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effectiveness of artesunate-amodiaquine vs. artemetherlumefantrine for the treatment of uncomplicated falciparum malaria in Nanoro, Burkina Faso: a non- inferiority randomised trial
Halidou Tinto et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2014)
The interplay between drug resistance and fitness in malaria parasites
Philip J. Rosenthal
MOLECULAR MICROBIOLOGY (2013)
Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia
Birgit Schramm et al.
MALARIA JOURNAL (2013)
Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial
Emmanuelle Espie et al.
MALARIA JOURNAL (2012)
Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data
Anne E. P. Frosch et al.
MALARIA JOURNAL (2011)
Declining Responsiveness of Plasmodium falciparum Infections to Artemisinin-Based Combination Treatments on the Kenyan Coast
Steffen Borrmann et al.
PLOS ONE (2011)
Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia
Harald Noedl et al.
CLINICAL INFECTIOUS DISEASES (2010)
Monitoring antimalarial resistance: launching a cooperative effort
Carol Hopkins Sibley et al.
TRENDS IN PARASITOLOGY (2010)
Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia
William O. Rogers et al.
MALARIA JOURNAL (2009)
Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia
Pharath Lim et al.
MALARIA JOURNAL (2009)
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
Richard T. Eastman et al.
NATURE REVIEWS MICROBIOLOGY (2009)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Geographic patterns of Plasmodium falciparum drug resistance distinguished by differential responses to amodiaquine and chloroquine
Juliana Martha Sa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mapping the Spread of Malaria Drug Resistance
Tim Anderson
PLOS MEDICINE (2009)
Pharmacokinetics and tolerability of artesunate and amodiaquine alone and in combination in healthy volunteers
Catherine Orrell et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up
George O. Adjei et al.
MALARIA JOURNAL (2008)
High efficacy of two artemisinin-based combinations (artemether-lumefantrine and artesunate plus amodiaquine) for acute uncomplicated malaria in Ibadan, Nigeria
C. O. Falade et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2008)
Efficacy and safety of artemisinin-based antimalarial in the treatment of uncomplicated malaria in children in southern Tanzania
Abdunoor M. Kabanywanyi et al.
MALARIA JOURNAL (2007)
Resistance-mediating Plasmodium falciparum pfcrt and pfmdr1 alleles after treatment with artesunate-amodiaquine in Uganda
Samuel L. Nsobya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Amodiaquine and artemether-lumefantrine select distinct alleles of the Plasmodium falciparum mdr1 gene in Tanzanian children treated for uncomplicated malaria
G. S. Humphreys et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso
Issaka Zongo et al.
CLINICAL INFECTIOUS DISEASES (2007)
In-vitro susceptibility of Plasmodium falciparum to monodesethylamodiaquine, dihydroartemisinin and quinine in an area of high chloroquine resistance in Rwanda
H Tinto et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2006)
Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania
A Mårtensson et al.
CLINICAL INFECTIOUS DISEASES (2005)
Chloroquine and sulphadoxine-pyrimethamine efficacy for uncomplicated malaria treatment and haematological recovery in children in Bobo-Dioulasso, Burkina Faso during a 3-year period 1998-2000
H Tinto et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2002)
Epidemiology of drug-resistant malaria
C Wongsrichanalai et al.
LANCET INFECTIOUS DISEASES (2002)
Using evidence to change antimalarial drug policy in Kenya
R Shretta et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2000)
Share Paper
